Q (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

+Studies 2000-2009 List
*Studies in Pre-2000 List

QUITTING CANNABIS*+ (See Also ADDICTION, WITHDRAWAL)
QUITTING OTHER DRUGS*+


QUITTING CANNABIS
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3050879/?toolmcentrez
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents (full–2012) http/ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3358737/
Reduction of dependence to cannabinoids by GLT-1 activating property of the betalactam antibiotic (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/23253111
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
A Randomized Double-blind, Placebo Controlled Trial of Venlafaxine-Extended Release for Co-occurring Cannabis Dependence and Depressive Disorders (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636166/
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3682150/
Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3641687/
Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636012/
top
Pharmacokinetic and Pharmacodynamic Profile of Supratherapeutic Oral Doses of Δ9 – THC in Cannabis Users (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3691290/
Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23711998
Cannabis use during a voluntary quit attempt: An analysis from ecological momentary assessment (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23664121
Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23685328
Self-Efficacy and Motivation to Quit Marijuana Use among Young Women (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23795877
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers (abst–2013) http/onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2012.00461.x/abstract
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465638/
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23095052
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a reversal design: a case study (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23909004
Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24186078
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt (abst–2013) http/www.sciencedirect.com/science/article/pii/S030646031300172X
The effects of cannabis use expectancies on self-initiated cannabis cessation (abst–2013) http/onlinelibrary.wiley.com/doi/10.1111/add.12233/abstract
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23098380
Baclofen in the management of cannabis dependence syndrome (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3896138/
Systematic review of N-acetylcysteine in the treatment of addictions (full–2014) http/www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014005031244&lng=en&nrm=iso&tlng=en
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4009342/
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
top
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24430917
Open-label pilot study of quetiapine treatment for cannabis dependence (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24963729
Achieving Cannabis Cessation – Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252394/
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24613633
Physical activity and cannabis cessation (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24629045
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
Cannabis use history and characteristics of quit attempts: A comparison study of treatment-seeking and non-treatment-seeking cannabis users (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250402/
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
Vilazodone for cannabis dependence: A randomized, controlled pilot trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ajad.12324/full
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with dependence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661990
Effects of quitting cannabis on respiratory symptoms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25837035
If at first you don’t succeed: characterization of smokers with late smoking abstinence onset (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637886
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26386827
Naltrexone Maintenance Decreases Cannabis Self Administration and Subjective Effects in Daily Cannabis Smokers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25881117
Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26461168
Assessing the efficacy of MOTI-4 for reducing the use of cannabis among youth in the Netherlands: a randomized controlled trial (link to PDF–2015) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900296-2/abstract
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25662704
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25725933
top
Separate and combined effects of gabapentin and [delta]9-tetrahydrocananbinol in humans discriminating [delta]9-tetrahydrocananbinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26313650
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901778-0/abstract
The prospective effects of perceived and laboratory indices of distress tolerance on cannabis use following a self-guided quit attempt (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26727009
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis (full–2016) http://www.karger.com/Article/FullText/445716
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis (abst–2016) http://www.sciencedirect.com/science/article/pii/S2451902215000099
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis (full–2016) http://www.sciencedirect.com/science/article/pii/S2451902215000099
Attempts to Stop or Reduce Daily Cannabis Use: An Intensive Natural History Study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877269/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net? (full–2016) http://www.mdpi.com/2076-328X/6/4/21/htm
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders (full–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748964/
Hippocampal harms, protection and recovery following regular cannabis use (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015201a.html
Social cognitive predictors of treatment outcome in cannabis dependence (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27883947
Treatment seeking in cannabis dependence: The role of social cognition (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27894043
Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26752416
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26888056
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26925704
Environmental cues and attempts to change in daily cannabis users: An intensive longitudinal study (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2900055-7/abstract
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900313-X/abstract
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27085870
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27156221
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261670
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27345297
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484692
Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27424166
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27485997 Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Oxytocin for the treatment of drug and alcohol use disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27603752
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27936376
top


QUITTING OTHER DRUGS
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Medical marijuana users in substance abuse treatment (full–2010) http/www.harmreductionjournal.com/content/pdf/1477-7517-7-3.pdf
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?toolubmed
Randomized, controlled, double-blind trial of taranabant for smoking cessation (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20191360
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3227620/?toolubmed
Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01467.x/full
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251 (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3697052/
top
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23685330
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4058760/
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice (full–2013) http/www.ncbi.nlm.nih.gov/pubmed/23303065
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23624062
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23490550
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT(1A) receptors in the dorsal raphe nucleus (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22862835
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23510307
Therapeutic benefits of cannabis: a patient survey (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress induced relapse in rats (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu025.long
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Can Cannabis be Considered a Substitute Medication for Alcohol? (abst–2014) http/alcalc.oxfordjournals.org/content/early/2014/01/07/alcalc.agt182.abstract?sid=7dda1d62-04a2-4bd8-88c2-9ffc481614b5
Can Cannabis be Considered a Substitute Medication for Alcohol? (full–2014) http://alcalc.oxfordjournals.org/content/early/2014/01/07/alcalc.agt182.full
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24553924
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161648/
Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25395060
Neuroinflammation as a possible link between cannabinoids and addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015)
http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25754762
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse (full–2015) http://www.nature.com/npp/journal/v40/n9/full/npp201562a.html
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26269227
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604178/
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26187456
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507533
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (full–2015) http://link.springer.com/article/10.1007%2Fs12630-015-0525-6
Cannabis Motives and Quitting Tobacco: Smoking Expectancies and Severity among Treatment-seeking Cigarette Smokers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26462254
Cannabis Motives and Quitting Tobacco: Smoking Expectancies and Severity among Treatment-seeking Cigarette Smokers (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599364/
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26455361
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to download-2015) http://www.rand.org/pubs/working_papers/WR1130.html
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use to (link through Elsevier to get link PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/26500166
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25662704
A safer alternative: Cannabis substitution as harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260134
top
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26331953
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Impacts of Changing Marijuana Policies on Alcohol Use in the United States (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acer.12942/full
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence (abst–2016)
http://www.sciencedirect.com/science/article/pii/S1734114016000037
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923145/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26806777
top
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26864774
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26888056
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27106177
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27234658
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833888
Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453054
The association between cannabis use and motivation and intentions to quit tobacco within a sample of Australian socioeconomically disadvantaged smokers (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27923866


Advertisements